Category: Licensing

Zooming Out On Compulsory Licensing Of Covid-19 Vaccines

The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind. The COVID-19 scare at the global level is posing threat to human life and the governments are deeply divided over an effort to endorse a temporary patent waiver on COVID-19 vaccines and grant of compulsory licenses. What is Compulsory Licensing? … Continue reading Zooming Out On Compulsory Licensing Of Covid-19 Vaccines

Read more »

Sisvel and Mitsubishi, and Xiaomi sign patent licensing deal to settle ongoing litigations

Recently, Sisvel and Mitsubishi jointly announced that the companies have entered into a patent license agreement covering the standard-essential patents (SEP) of Mitsubishi Electric and Sisvel in the field of mobile communication. This deal brings to an end the global dispute between the three companies, which has spanned the courts in China, Germany, Italy, the … Continue reading Sisvel and Mitsubishi, and Xiaomi sign patent licensing deal to settle ongoing litigations

Read more »

DelSiTech and Visus Therapeutics enter into Patent Licensing Arrangement

Recently, DelSiTech Ltd. (“DelSiTech”), a Finland-based drug delivery company entered into a patent licensing agreement over DelSiTech’s patents with Visus Therapeutics (“Visius”), a US-based company. This is a worldwide exclusive licensing agreement. Both companies are working on six development programs for eye care solutions targeting the management of ocular diseases of the back and front … Continue reading DelSiTech and Visus Therapeutics enter into Patent Licensing Arrangement

Read more »

ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies

Recently, Dublin, Ireland-based biotechnology company, ERS Genomics Limited (“ERS”), has signed a nonexclusive license agreement with Iowa-based Cellular Engineering Technologies (“CET”) to grant access to its CRISPR-Cas9 patent portfolio. The financial terms of the agreement were not disclosed. ERS was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property for use as a … Continue reading ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies

Read more »

Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)

Settling an over three old patent infringement dispute, Indian pharmaceutical major, Sun Pharmaceuticals and its subsidiary, including US subsidiary (“Sun”), has reached a settlement with Celgene Corporation (“Celgene”), a subsidiary of pharmaceutical major Bristol Myers Squibb (BMS), to resolve and settle the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a … Continue reading Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)

Read more »

Bajaj Healthcare Files Compulsory License with Indian Patent Office for Baricitinib

Recently, drug manufacturer, Bajaj Healthcare Limited issued a press release stating that they have filed a compulsory license application with the Indian Patent Office seeking permission to manufacture both active pharmaceutical ingredients (raw materials) and formulation of Baricitinib under the Indian Patents Act. Baricitinib is essentially a drug approved in the US and European Union, … Continue reading Bajaj Healthcare Files Compulsory License with Indian Patent Office for Baricitinib

Read more »

Elli Lilly Enters into Licensing Deals with Indian Companies

Recently, Elli Lilly, a US-based major Pharmaceutical company, has entered into licensing agreements with a number of Indian drug manufacturers for the manufacture of and supply of Baricitinib in India which is showing promise as a drug for the treatment of Covid-19. The licensing agreement with Eli Lilly is voluntary, royalty-free, and non-exclusive in nature … Continue reading Elli Lilly Enters into Licensing Deals with Indian Companies

Read more »

Merck Enters into Licensing Deal with Five Indian Companies for Supply of Oral Covid-19 Drug

Recently, Merck, also known as MSD, has entered into licensing agreements with five Indian generics drug manufacturers to manufacture and supply oral Covid-19 drug Molnupiravir. MSD India is a wholly-owned subsidiary of Merck Sharp & Dohme (MSD) and is known as Merck & Co., Inc, in the United States and Canada. Under the agreements, Merck … Continue reading Merck Enters into Licensing Deal with Five Indian Companies for Supply of Oral Covid-19 Drug

Read more »

Concept Of Compulsory Licensing Under The Patents Act

An inventor is allotted with the patent right in exchange for disclosing its invention. Apart from the inventor of that patent, the public is being benefited most. Therefore it must be taken into consideration that the invention is made surely available to the public. But there seems to a danger of misuse of such monopolistic … Continue reading Concept Of Compulsory Licensing Under The Patents Act

Read more »

InterDigital vs Xiaomi: An interesting case on Confidentiality Club in Standard Essential Patents Litigation

Recently, the Delhi High Court decided on a patent infringement suit filed by Interdigital Technology Corporation (“InterDigital”), a US-based mobile and video Research & Development company, against Xiaomi Corporation (“Xiaomi”), a China-based internet and telecommunication company. An interesting aspect that was put forth for the consideration of the single judge Bench of the Delhi High … Continue reading InterDigital vs Xiaomi: An interesting case on Confidentiality Club in Standard Essential Patents Litigation

Read more »

Archives

  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • September 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010